Term
|
Definition
- thiazide diuretic
- Na/Cl transporter
- sulfonamide=targeting
- 3-4 saturation = ↑ diuretic effect
|
|
|
Term
|
Definition
- Thiazide diuretic
- Na/Cl transporter
- Sulfonamide = targeting
- C-3 lipophilic group = long duration, enhances effect
- N-2 subsitution = ↑ duration
- C3-4 saturation = ↑ diuretic effect
|
|
|
Term
|
Definition
- Loop diuretic
- Na/K/2Cl symporter
- arylsulfonamide= targeting
- 2-amino benzoic acid
- hypokalemia
|
|
|
Term
|
Definition
- Carbonic anhydrase inhibitor
- Thiadiazole
- Sulfamoyl(sulfonamide)= targeting
- Sulfonamide = acidic
- Used in glaucoma
|
|
|
Term
|
Definition
- Carbonic anhydrase inhibitor
- Sulfonamide = targeting
- Ionizable amine = water soluble
- Used for glaucoma
|
|
|
Term
|
Definition
- Thiazide-like diuretic
- Sulfamoyl = targeting
- C-6 chloro enhances effect
- No sulfonamide group, replaced with amide = less soluble = longer duration
|
|
|
Term
|
Definition
- Aldosterone Receptor antagonist
- Steroid ring required for antagonism
- Closed lactone for activity
- Very low H bonding
- 3-keto-4-ene A ring needed for antagonism
- ↑ K, H+
- ↓ Na, Cl, H2O
|
|
|
Term
|
Definition
- Osmotic diuretics(urea&mannitol)
- Osmotically draws water from tissues into tubule
- Polar molecules
|
|
|
Term
|
Definition
- Na/K exchange channel inhibitor (triamterene)
- Pteridine ring
- Na not absorbed, K not excreted
- Used along with thiazides
|
|
|
Term
|
Definition
- Lisinopril ACE-I
- C terminal carboxyl required for binding
- large ring=increase potency
- Zinc binding region with COOH
- No ester = active
|
|
|
Term
|
Definition
- ACE inhibitor (enalapril)
- C terminal carboxyl required for binding
- Large heterocycle ring = increase potency
- Zinc binding region has carboxyl after hydrolysis.
- With ester is a prodrug.
- Binds to ACE, prevents conversion of AT1→AT2, prevents bradykinin degradation.
|
|
|
Term
|
Definition
- ARB (losartan)
- Imidazole
- N-1 variable region with biphenyl substituent
- Acidic group on ortho(tetrazole) required
- C-2 has unbranched linear hydrocarbon
- C-4 electron withdrawing group (Cl)
- C-5 H-bonding or ionic interaction group (OH,COOH)
- Blocks binding of AT2 to its receptor
- Prevents vasoconstriction, aldosterone release, catecholamine release, renal Na reabsorption.
|
|
|
Term
|
Definition
- Renin inhibitor(aliskiren)
- Prevents angiotensinogen→ AT1
- Binds to Renin
- Hydroxyethylene has OH instead of CO(middle)
- Stops peptide hydrolysis by aspartyl protease
|
|
|
Term
|
Definition
- HMG-CoA reductase inhibitor (lisinopril)
- Decrease endogenous biosynthesis of cholesterol
- Decalin ring-hydrophobic anchor(needs double bonds)
- Ester(can be ether) slight ↓ activity
- Added methyl on ester increase potency.
- Closed lactone ring = prodrug
|
|
|
Term
|
Definition
- HMG-CoA reductase inhibitor(pravastatin)
- ↓ biosynthesis of endogenous cholesterol
- Decalin ring with double bonds.
- Ester side chain
- Has β hydroxyl group on decalin = ↑hydrophilicity, distribution and hepatic specificity
- Open lactone = active, not prodrug
|
|
|
Term
|
Definition
- Fibric acid derivative(fenofibrate)
- Stimulates lipoprotein lipase
- PPRα-antagonist= ↑ expression of HDL receptors
- Decreases triglycerides
- Aromatic ring = essential, Cl increases t1/2
- Ether,carbonyl or ester in middle,not required.
- Spacer in middle could be phenyl
- Isobutryic component-essential
|
|
|
Term
|
Definition
- Ezetimibe
- Prevents absorption of cholesterol at the brush border(exogenous)
- Reduces hepatic cholesterol store(endogenous) and increased clearance of plasma choleterol(endogenous).
- Beta lactam
- Fluorines decrease metabolism
- Beta OH targets drug to intestine
|
|
|
Term
|
Definition
- Calcium channel blocker(amlodipine) dihydropyradine
- L type vascular smooth muscle
- Dihydropyradine ring required
- Phenyl group on C-4 with ortho or meta substituent, keeps the rings perpendicular
- Esters in positions 3,5 are required, if acids = inactive.
- C2,6 are bulk
|
|
|
Term
|
Definition
- Calcium Channel blocker(diltiazem) benzothiazepine
- Blocks cardiac Ltype calcium channels
|
|
|
Term
|
Definition
- Calcium channel blocker (verapamil) arylalkylamine
- Blocks cardiac L-type calcium channels
|
|
|